Merck raised its 2020 adjusted profit outlook as the pharma giant is witnessing high demand for its cancer drug Keytruda as well as …
Merck (MRK) has announced that the U.S.
AstraZeneca announced that its Lynparza drug has been recommended for marketing authorization in the European Union (EU) for patients with metastatic prostate cancer (mCRPC) …
Seattle Genetics (SGEN) shares are up 9% in pre-market hours today following the news that Merck will make a $1 billion equity investment …
Merck & Co. (MRK) has now started testing its experimental Covid-19 vaccine candidate V591 in healthy volunteers, according to a report from the …
The pharmaceutical industry is considered to be more resilient in difficult economic times compared to other industries. However, this time around, the coronavirus-led …
Merck & Co. announced on Monday that Japan’s regulator approved the drugmaker’s Keytruda therapy for the treatment of patients with advanced esophageal squamous …
Merck & Co. and Hanmi Pharmaceutical on Tuesday entered into an exclusive licensing agreement to develop efinopegdutide (formerly HM12525A), an investigational once-weekly therapy …
Goldman Sachs on Monday upgraded pharma giant Merck & Co. to Buy from Hold, citing its strong pipeline and cancer drug Keytruda.
Merck (MRK) and Novocure (NVCR) have entered into a clinical trial collaboration agreement to develop Tumor Treating Fields together with Merck’s anti-PD-1 therapy …
